Preventive Care Checklist Form Explanations
Preventive Care Checklist Form Explanations
Education/Counseling
Behavioural
Folic acid (A):
To prevent neural tube defects (NTD) in all women
capable of becoming pregnant
Low risk-women: Folic acid supplementation of 0.4 to 0.8 mg
daily taken at least one month before and three months after
conception.
High-risk women (previous pregnancy with NTD):
Supplementation with 4 mg folic acid daily during 3 months
before and 3 months after conception reduces recurrence.
Adverse nutritional habits (B):
Prevention of coronary artery disease, colon cancer
Provide general dietary advice: decrease fat, increase fiber.
Those at increased risk, consider referral to a clinical
nutritionist or other professional with specialized nutritional
expertise.
Dietary advice on fat/cholesterol (B):
Prevent coronary heart disease
Decrease intake of total fat, saturated fat, and cholesterol
1
Calcium 1000-1500mg/day :
Prevent osteoporosis
The Osteoporosis Society of Canada (OSC) recommends
adults have 1000 to 1500 mg of elemental calcium per day.
If this amount cannot be provided by diet alone (usually
three or more servings of dairy products), then calcium
1
supplementation should be recommended.
1
Vitamin D :
Prevent osteoporosis
The OSC recommends 200 IU/day in 50-64 year olds
400-800 IU/ day in people 65 years or with osteoporosis
From CTFPHC (B): Calcium and vitamin D supplementation
alone prevents osteoprotic fractures in postmenopausal women
without documented osteoprosis.
Moderate physical activity (B):
Prevention of cardiovascular disease and hypertension.
Physical activity can also contribute to the prevention of
obesity, Type II diabetes mellitus and osteoporosis.
Recommend moderate-level physical activity performed
consistently to accumulate 30 minutes or more over the course
of most days of the week.
Moderate intensity physical activities include: normal
walking, golfing on foot, slow biking, raking leaves, cleaning
windows, slow dancing, light restaurant work.
Note: Doing moderate physical activity is a B
recommendation but physician counseling is a C.
Avoid sun exposure, use protective clothing (B):
Prevent skin cancer
Evidence from epidemiologic studies focusing on etiology of
melanoma, prudence and low cost/side-effects, supports the
avoidance of excessive sun exposure at mid-day, plus the use
of protective clothing.
Sunscreen use is a C recommendation for general
population (last updated 1994).
Safe sex practices/ Sexually Transmitted Diseases counseling
(esp. Gonorrhea counseling) (B):
Prevent transmission of sexually transmitted diseases.
Abstinence is most effective, fair evidence to use condoms.
Smoking Counseling To Prevent Tobacco-Caused Disease
Smoking cessation (A): counseling effective to reduce the
proportion of smokers.
Nicotine replacement therapy (A): may be offered as an
adjunct to smoking cessation; it increases cessation rates.
Please note:
Bold = Good evidence
Italics = Fair evidence (from the Canadian Task Force on Preventive HealthCare)
Plain text = Guidelines from other Canadian sources
(See reverse for references, insert for explanations)
page 1 of 3
(Page 2/3)
Functional Inquiry
Depression (B): Screen adults if there are integrated programs for feedback to patients and access to case management or mental
health care:
1) Over the past 2 weeks, have you felt little pleasure in doing things?
2) Over the past 2 weeks, have you felt down, depressed or hopeless?
Positive screen is a yes answer to one or both questions.
Physical Examination
Blood Pressure(B): To screen for hypertension.
If BP is mildly elevated do three further readings over 6
months.
If BP severely elevated, shorten intervals between readings.
Treatment of hypertension in adults lowers risk of stroke,
cardiac events and death (A recommendation).
Waist to Hip Ratio (WHR) 7: WHR >1.0 for men and >0.85 for
women is considered a marker for abdominal obesity.
Immunizations
Tetanus (A):
Routine booster doses every 10 years if had primary series
Adults without a primary series need three doses.
Primary adult series are given at time 0, 1-2 months, and 65
12 months.
Pneumococcal vaccine (A)4: To all persons 65 years
High Risk: All persons >5 years with the following
conditions: sickle cell disease, asplenia, splenic dysfunction,
chronic cardiorespiratory disease (except asthma), cirrhosis,
alcoholism, chronic renal disease, nephrotic syndrome,
diabetes mellitus, chronic CSF leak, HIV infection, smokers,
and other conditions associated with immunosuppression
(Hodgkins disease, lymphoma, multiple myeloma, induced
immunosuppression for organ transplantation).
Influenza vaccine (A)4: Annually immunize the following:
All adults
High risk groups include:
65 years of age
Adults and children with chronic cardiac or pulmonary
disorders (including bronchopulmonary dysplasia, cystic
fibrosis, and asthma) severe enough that they have regular
follow-up and hospital care,
Adults and children with chronic diseases, eg. diabetes
mellitus, metabolic diseases, cancer, immunodeficiency,
immunosuppression, renal disease, anemia, and
hemoglobinopathy,
People at high risk of influenza complications who are
traveling to places where the virus is likely present,
Health care workers and other personnel who have
significant contact with people in the high-risk groups
previously described
Please note:
Bold = Good evidence
Italics = Fair evidence (from the Canadian Task Force on Preventive HealthCare)
Plain text = Guidelines from other Canadian sources
(See reverse for references, insert for explanations)
page 2 of 3
(Page 3/3)
Investigations/Labs
Mammography with Clinical Breast Exam (A):
Screen women aged 50-69 every 1-2 years for breast
cancer.
C recommendation for women aged 40-49 at average risk.
Frequent screening may be required (every 12-18 months)
in 40-49 year group.
Upon reaching the age of 40, women should be informed of
the potential benefits and risks of screening mammography to
decide at what age they wish to begin screening.
Colorectal cancer screening of patients 50 years:
Hemoccult multiphase every 1-2 years (A) OR
Flexible Sigmoidoscopy (B) (Frequency not established)
Colonoscopy (Frequency not established) 8
Cervical cytology (B): See Pap explanation.
Screening for Sexually Transmitted Infections in High Risk
Populations:
High-risk Populations: individuals under age 30 with at least
2 sexual partners in the previous year or age 16 years at first
intercourse, prostitutes, sexual contacts of individuals known
to have an STI.
Syphilis (A): Serology testing
Gonorrhea (A): Screen with Gram stain and culture of
cervical or urethral specimen. Urine testing available.
Chlamydia (B): Screen with culture or polymerase chain
reaction. Urine testing available.
HIV (A): Screen with blood test
Hepatitis B virus (HBV)4,5: Screen with hepatitis B surface
antigen (HBsAg) in blood.
Bone Mineral Density: Screen for osteoporosis
From CTFPHC (B):
To prevent fragility fractures: Screen postmenopausal women by
DEXA if over 65 years of age or have a history of previous
fracture, or have a have an Osteoprosis Risk Assessment
Instrument score 9 or have a SCORE score 6.
1
From Osteoporosis Society of Canada :
Screen if 1 major or 2 minor risk factor(s)
Major risk factors: age > 65, vertebral compression fracture,
fragility fracture after age 40, family history of osteoporotic
fracture, systemic glucocorticoid therapy of >3 months duration,
malabsorption syndrome, primary hyperparathyroidism, propensity
to fall, osteopenia apparent on x-ray film, hypogonadism, early
menopause (< 45 years)
Minor Risk Factors: rheumatoid arthritis, past history of clinical
hyperthyroidism, chronic anticonvulsant therapy, low dietary
calcium intake, smoker, excessive alcohol intake, excessive
caffeine intake, weight <57 kg, weight loss >10% of weight at age
25, chronic heparin therapy
Diabetes Mellitus
Hypertension
Evidence of atherosclerosis
Screen at any age adults with major CAD risk factors
Screening frequency should be every one to three years or
sooner.
2
Member of high
Vascular disease
risk population
History of
(Aboriginal,
gestational DM or
Hispanic, Asian,
macrosomic infant
South Asian or
Schizophrenia
African descent)
Polycystic ovarian
History of impaired syndrome
glucose tolerance
Other risk factors
or impaired fasting
glucose
FPG 7.0 mmol/L is diagnostic of diabetes mellitus
From CTFPHC screen adults with hypertension or
hyperlipidemia to prevent cardiovascular events and death (B).
References
Unless otherwise stated, recommendations come from 1. The Canadian Task Force on Preventive Health Care: The Canadian Guide to Clinical
Preventive Health Care. Ottawa: Minister of Supply and Services Canada and http://www.ctfphc.org/
1. Scientific Advisory Board, Osteoporosis Society of Canada. Clinical practice guidelines for the diagnosis and management of osteoporosis.
CMAJ
2002;167(10 suppl):S1-34.
2. Working Group on Hypercholesterolemia and Other Dyslipidemias. Recommendations for the management and treatment of dyslipidemia and
the prevention of cardiovascular disease: 2003 update. Can J Cardiol 2006;22 (11) 913-927.
3. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Assn 2003 Clinical Practice Guidelines for
the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2003;27 (Suppl 2).
th
4. National Advisory Committee on Immunization. Canadian Immunization Guide, 7 edition. Ottawa: Minister of Public Works and Government
Services Canada; 2006.
5. Expert Working Group on Canadian Guidelines for STIs. Canadian Guidelines on Sexually Transmitted Infections, 2006 edition. Ottawa: Public
Health Agency of Canada.
6. Canadian Guidelines for Body Weight Classification in Adults. Health Canada. 2003; available at http://www.healthcanada.ca/nutrition/.
7. WHO Technical Series. Obesity: preventing and managing the global epidemic. Geneva, World Health Organization 2004.
8. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation Committee on Colon Cancer Screening. Guidelines
on colon cancer screening. Can J Gastroenterol 2005; 18 (2): 93-99.
Please note:
Endorsed by:
Bold = Good evidence
Italics = Fair evidence (from the Canadian Task Force on Preventive HealthCare)
Plain text = Guidelines from other Canadian sources
See reverse for references, insert for explanations)
page 3 of 3